Lataa...
Antibody-Based Therapies in Multiple Myeloma
The unmet need for improved multiple myeloma (MM) therapy has stimulated clinical development of monoclonal antibodies (mAbs) targeting either MM cells or cells of the bone marrow (BM) microenvironment. In contrast to small-molecule inhibitors, therapeutic mAbs present the potential to specifically...
Tallennettuna:
| Päätekijät: | , |
|---|---|
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
Hindawi Publishing Corporation
2011
|
| Aiheet: | |
| Linkit: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3200112/ https://ncbi.nlm.nih.gov/pubmed/22046572 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1155/2011/924058 |
| Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|